Profil
Christopher W.
Morgan is currently Director at Alpha Cancer Technologies, Inc. Formerly, Mr. Morgan was Director at Spectra7 Microsystems, Inc. from 2021 to 2025 and Partner at Skadden, Arps, Slate, Meagher & Flom LLP.
Mr. Morgan earned an MBA from the University of Toronto.
Aktiva positioner av Christopher Morgan
| Företag | Position | Start |
|---|---|---|
Alpha Cancer Technologies, Inc.
Alpha Cancer Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures chemotherapeutic drugs | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Christopher Morgan
| Företag | Position | Slut |
|---|---|---|
| SPECTRA7 MICROSYSTEMS INC. | Direktör/Styrelseledamot | 2025-04-28 |
Skadden, Arps, Slate, Meagher & Flom LLP
Skadden, Arps, Slate, Meagher & Flom LLP Miscellaneous Commercial ServicesCommercial Services Operates as a legal firm | Företagsledare/Principal | - |
Christopher Morgans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Skadden, Arps, Slate, Meagher & Flom LLP
Skadden, Arps, Slate, Meagher & Flom LLP Miscellaneous Commercial ServicesCommercial Services Operates as a legal firm | Commercial Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spectra7 Microsystems, Inc.
Spectra7 Microsystems, Inc. SemiconductorsElectronic Technology Manufactures semiconductor products | Electronic Technology |
Alpha Cancer Technologies, Inc.
Alpha Cancer Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures chemotherapeutic drugs | Health Technology |
















